USFDA approves Pfizer’s Velsipity for adults with Ulcerative Colitis

Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials

Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines

Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug

Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America

Cosmo and Glenmark sign distribution and license agreements for Winlevi in Europe and South Africa

Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries

Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia

With this, the company has secured 511 marketing approvals for its oncology products across 66 countries

RML Hospital inaugurates India’s first dedicated OPD for transgenders

Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community

Insmed announces positive results from Phase III arise study of ARIKAYCE

Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score

BioNTech appointing James Ryan as Chief Legal Officer

Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry

Lincoln Pharmaceuticals posts Q1 FY24 standalone net profit at Rs. 19.01 Cr

Govt. passes National Dental Commission Bill, 2023

The National Dental Commission Act 2023, will introduce a groundbreaking regulatory framework by establishing the National Dental Commission